Goldman Sachs’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.2M | Sell |
|
|||||
|
2025
Q1 | $17.2M | Buy |
|
|||||
|
2024
Q4 | $23.7M | Buy |
|
|||||
|
2024
Q3 | $21.3M | Sell |
|
|||||
|
2024
Q2 | $28.3M | Buy |
|
|||||
|
2024
Q1 | $29.4M | Buy |
|
|||||
|
2023
Q4 | $25.1M | Buy |
|
|||||
|
2023
Q3 | $25.2M | Sell |
|
|||||
|
2023
Q2 | $40.9M | Buy |
|
|||||
|
2023
Q1 | $32M | Buy |
|
|||||
|
2022
Q4 | $21.9M | Sell |
|
|||||
|
2022
Q3 | $54.9M | Buy |
|
|||||
|
2022
Q2 | $43.9M | Buy |
|
|||||
|
2022
Q1 | $38.6M | Sell |
|
|||||
|
2021
Q4 | $117M | Buy |
|
|||||
|
2021
Q3 | $130M | Sell |
|
|||||
|
2021
Q2 | $161M | Buy |
|
|||||
|
2021
Q1 | $62.8M | Sell |
|
|||||
|
2020
Q4 | $57.6M | Buy |
|
|||||
|
2020
Q3 | $10.7M | Buy |
|
|||||
|
2020
Q2 | $2.64M | Buy |
|
|||||
|
2020
Q1 | $1.14M | Sell |
|
|||||
|
2019
Q4 | $1.37M | Sell |
|
|||||
|
2019
Q3 | $2.04M | Sell |
|
|||||
|
2019
Q2 | $3.62M | Buy |
|
|||||
|
2019
Q1 | $2.31M | Sell |
|
|||||
|
2018
Q4 | $2.21M | Buy |
|
|||||
|
2018
Q3 | $2.8M | Buy |
|
|||||
|
2018
Q2 | $2.38M | Buy |
|
|||||
|
2018
Q1 | $691K | Sell |
|
|||||
|
2017
Q4 | $2.5M | Buy |
|
|||||
|
2017
Q3 | $794K | Sell |
|
|||||
|
2017
Q2 | $777K | Buy |
|
|||||
|
2017
Q1 | $573K | Sell |
|
|||||
|
2016
Q4 | $2.13M | Buy |
|
|||||
|
2016
Q3 | $2.66M | Buy |
|
|||||
|
2016
Q2 | $3.07M | Buy |
|